|
Name |
L-dihydroanticapsin
|
Molecular Formula | C9H15NO4 | |
IUPAC Name* |
(2S)-2-amino-3-[(1R,2S,5R,6S)-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]propanoic acid
|
|
SMILES |
C1C[C@H]([C@H]2[C@@H]([C@@H]1C[C@@H](C(=O)O)N)O2)O
|
|
InChI |
InChI=1S/C9H15NO4/c10-5(9(12)13)3-4-1-2-6(11)8-7(4)14-8/h4-8,11H,1-3,10H2,(H,12,13)/t4-,5-,6+,7+,8-/m0/s1
|
|
InChIKey |
YMLXTGCTHGQQKS-TXXZRHAASA-N
|
|
Synonyms |
L-dihydroanticapsin; CHEBI:85360; C20940; Q27158510; 3-[(1R,2S,5R,6S )-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]-L-alanine
|
|
CAS | NA | |
PubChem CID | 86583396 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 201.22 | ALogp: | -3.1 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 96.1 | Aromatic Rings: | 2 |
Heavy Atoms: | 14 | QED Weighted: | 0.549 |
Caco-2 Permeability: | -6.023 | MDCK Permeability: | 0.00044032 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.578 |
Human Intestinal Absorption (HIA): | 0.917 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.127 |
Blood-Brain-Barrier Penetration (BBB): | 0.388 | Plasma Protein Binding (PPB): | 7.50% |
Volume Distribution (VD): | 0.425 | Fu: | 83.30% |
CYP1A2-inhibitor: | 0.025 | CYP1A2-substrate: | 0.042 |
CYP2C19-inhibitor: | 0.037 | CYP2C19-substrate: | 0.059 |
CYP2C9-inhibitor: | 0.016 | CYP2C9-substrate: | 0.218 |
CYP2D6-inhibitor: | 0.033 | CYP2D6-substrate: | 0.182 |
CYP3A4-inhibitor: | 0.012 | CYP3A4-substrate: | 0.028 |
Clearance (CL): | 7.675 | Half-life (T1/2): | 0.813 |
hERG Blockers: | 0.057 | Human Hepatotoxicity (H-HT): | 0.433 |
Drug-inuced Liver Injury (DILI): | 0.034 | AMES Toxicity: | 0.019 |
Rat Oral Acute Toxicity: | 0.117 | Maximum Recommended Daily Dose: | 0.034 |
Skin Sensitization: | 0.419 | Carcinogencity: | 0.173 |
Eye Corrosion: | 0.015 | Eye Irritation: | 0.104 |
Respiratory Toxicity: | 0.884 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005742 | 0.316 | D02UDJ | 0.310 | ||||
ENC005743 | 0.300 | D0P0QK | 0.273 | ||||
ENC000767 | 0.278 | D00ENY | 0.260 | ||||
ENC000795 | 0.245 | D0X5SI | 0.245 | ||||
ENC000447 | 0.245 | D01OPV | 0.245 | ||||
ENC000550 | 0.245 | D0XN8C | 0.244 | ||||
ENC000760 | 0.245 | D03CHT | 0.241 | ||||
ENC000137 | 0.245 | D05HXX | 0.236 | ||||
ENC006058 | 0.235 | D01JIA | 0.235 | ||||
ENC001215 | 0.235 | D0Z4EI | 0.218 |